MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Regional Innovation Clusters (RICs), Incubators, Accelerators, Technology Transfer, SBIR/STTR, OTA, Non-Traditionals & Triple Helix
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Triple Helix Cluster & Developments: Massachusetts
*Industry: Massachusetts
Organogenesis Holdings, Inc. (NASDAQ:ORGO)
Organization & Developments: Organogenesis
Parents
Organogenesis Holdings, Inc. (NASDAQ:ORGO)
Children
*Bio-active wound healing
*Oral Regeneration
*Organogenesis Holdings is a holding company that, through its subsidiaries, develops and commercializes drugs for wound care, surgical, and sports medicine markets.
*Regenerative medicine company with the unique skill set to take complex, living therapies from research and development (R&D), through manufacturing, to successful commercialization
2011: Exceeded $100 million in revenue and 500 employees
2020: Organogenesis Holdings: Accumulate On Dips
2020: Organogenesis: Revenue Generating Regenerative Medicines Company Looking Interesting
2022: Organogenesis: Finding A Spot For This Regenerative Medicines Company In My 'Bio Boom' Portfolio_seekingalpha.com
2024: Is Organogenesis a Hidden Gem in the Biotech Sector?
2024: Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
2024: Organogenesis: Lurking Disruption With Recovery To Follow
2025: Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario
2025: Organogenesis: Build On Weakness For Big ReNu Knee OA Payday
2025: Organogenesis: Mixed ReNu Data, But Policy Tailwinds And Growth Remain Bullish
2025: Organogenesis: Transformational Changes Taking Shape
Jumps
*Key People: Organogenesis
Finance & Acquisitions: Organogenesis